MOF Budget Examiner Presses for “Full” Annual Re-Pricing, Stepwise Cut in 2% Buffer Zone If No Reasonable Basis Given

May 20, 2022
MOF Budget Examiner Jun Hitomatsu Drug prices should be revised annually on a full basis, without differentiating “off-years” from years with medical fee revisions in order to reduce the national burden and eke out savings for innovation, a senior Ministry...read more